Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-20

Clinical Trial Update: RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. [Phase 4]

View source ↗

Summary

Phase 4 randomized trial compares analgesic efficacy of four opioid strategies (fentanyl, oxycodone, buprenorphine, morphine) for moderate-to-severe cancer pain…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL (FENTANYL)
  • Morphine (morphine)
  • Oxycodone (oxycodone)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Cancer, Cancer Pain | Phase 4 | Status: COMPLETED | Results posted: 2015-11-20